Search terms
Sep 07, 2023
Martini Hospital, an innovative center of clinical excellence with a specialized cardiac arrhythmia center in Groningen, the Netherlands, recently implemented a newly designed service for continuous remote cardiac monitoring. The first service of its kind in the Netherlands, Philips’ user-friendly ePatch couples with the company’s AI-powered Cardiologs analytics platform to replace conventional, more labor-intensive Holter monitor devices that can be cumbersome for patients to wear, labor-intensive to manage, and only provide cardiac monitoring data over a limited timeframe. The new solution empowers Martini Hospital’s cardiology and neurology teams with an end-to-end solution that enhances their ability to detect and diagnose atrial fibrillation – a common and potentially life-threatening cardiac arrhythmia [2]. The service has already proven invaluable to the hospital's cardiology team, enabling them to detect arrhythmias in multiple patients that would have gone unnoticed using traditional testing methods. Atrial fibrillation is the world’s most common cardiac arrhythmia. It significantly increases the risk of stroke, dementia, and heart failure, but frequently goes undetected because it often lacks noticeable symptoms and may only occur infrequently. To find the cause, patients are often asked to visit their general practitioner or cardiologist, who typically performs an electrocardiogram (ECG).
“This innovative new service marks a significant leap forward in detecting and managing cardiac arrhythmias,” said Dr. Robert Tieleman, cardiologist at the Martini Hospital. “With its advanced technology and user-friendly, end-to-end design, this new service enhances our ability to monitor and support heart and stroke patients. Especially, the prolonged monitoring period and the cleaner registrations of data during exercise improves the diagnostic yield which can have important consequences for the individual treatment of the patient and may eventually improve outcomes and quality of life.”
![Dutch introduction Philips ePatch (2) Dutch introduction Philips ePatch (2)](https://i0.wp.com/www.philips.com/c-dam/corporate/newscenter/nl/standard/resources/2023/telegraaf-een-pleister-die-het-hart-in-de-gaten-houdt/epatch-thumbnail.jpg)
Greater patient comfort and enhanced diagnostic confidence The new ePatch-based service allows for a longer period of continuous recording and prolonged insights into a patient’s health condition. The ePatch comes as a ‘ready-to-go’ unit. A cardiologist or nurse applies the device to the patient’s sternum, located in the center of the chest, during a visit to the doctor’s office. It is comfortable and splash-proof and can even be worn in a shower, allowing patients to maintain their daily routines, including sports activities. The device’s sensor continuously records and stores the patient's heart activity day and night for up to 14 days. The recorded data is then retrieved and analyzed by AI-based software that searches for irregularities that indicate heart arrhythmias and makes an automatically generated concept report with findings for the clinical teams to evaluate further. Previously, patients had to use conventional Holter monitors that required up to seven to ten ECG electrodes to be applied to the patient's chest, linked to a bulky control unit worn on a belt or necklace. These bulkier Holter monitors typically limit patients’ ability to go about their normal daily activities, which could impact diagnostic yield. With traditional Holter monitors, the application process, data analysis and reporting, and cleaning process afterward can be labor-intensive and inefficient for clinical staff. Additionally, a traditional Holter monitor is also relatively costly, which could often limit their availability, causing patients to wait longer for their tests, and they typically only allow 72 hours of continuous wearing and recording. “With the longer recording capability of the ePatch, we have a higher chance of detecting an arrhythmia,” said Alexandra Bevers, heart function lab technician and Holter analyst at the Martini Hospital. “Because the patch is a single device that adheres well to the patient’s chest, compared to our traditional Holter with 7 leads, this results in minimal interference and a more reliable recording, allowing ECG analysts like me to evaluate the data quite quickly and provide the cardiologists with the information needed to support a diagnosis.” 56-year-old stroke patient exemplifies the program's impact Marco: “After my stroke, I had been monitored in the hospital for 24 hours twice before. Nothing was found during those times. I am relieved that something has now been discovered that the clinical team believes has been causing my problems and can be prevented with the right medication.” Beyond enhancing patient experiences and diagnoses, the hospital's cardiology department aims to significantly alleviate the growing workload on its staff through this program while also driving cost efficiencies.
Marco, a 56-year-old patient recovering from a stroke, exemplifies the program's impact. His Philips ePatch identified atrial fibrillation on the fifth day of his monitoring program, shedding important light on the potential cause of his initial stroke. Utilizing the insights provided by the ePatch, his clinical team has been able to provide Marco with a proactive personalized treatment to help avert future heart or stroke problems.
![Dutch introduction Philips ePatch (3) Dutch introduction Philips ePatch (3)](https://i0.wp.com/www.philips.com/c-dam/corporate/newscenter/nl/standard/resources/2023/telegraaf-een-pleister-die-het-hart-in-de-gaten-houdt/lady-having-breakfast-while-wearing-epatch.jpg)
Building on years of success in the U.S. The introduction of this initiative in the Netherlands is built on years of successful experience in the United States, where yearly more than 1.2 million patients are being monitored using comparable Philips wearable e-patches and remote telemetry programs. These programs have demonstrated heightened atrial fibrillation detection and major cost savings per patient. To learn more about Philips’ broad portfolio of ECG solutions, visit the Gobio website. [1] New post-cryptogenic stroke remote telemetry study demonstrates increased atrial fibrillation detection and USD 4 million in cost savings using initial Philips BioTel Heart MCOT monitoring
[2] Heart.org
Share on social media
- https://www.philips.com/a-w/about/news/archive/standard/news/articles/2023/20230907-dutch-introduction-philips-epatch.html Link copied
Topics
Cardiology Patient monitoring Patient data News article
Contact
![Dutch introduction Philips ePatch (4) Dutch introduction Philips ePatch (4)](https://i0.wp.com/www.philips.com/c-dam/corporate/newscenter/global/media-contacts/profile-joost-maltha.jpg)
Joost Maltha
Philips Global Press Office Tel: +31 6 10 55 8116
By clicking on the link, you will be leaving the official Royal Philips ("Philips") website. Any links to third-party websites that may appear on this site are provided only for your convenience and in no way represent any affiliation or endorsem*nt of the information provided on those linked websites. Philips makes no representations or warranties of any kind with regard to any third-party websites or the information contained therein.
You are about to visit a Philips global content page
![Dutch introduction Philips ePatch (5) Dutch introduction Philips ePatch (5)](https://i0.wp.com/www.philips.com/c-dam/corporate/newscenter/global/media-contacts/profile-meredith-amoroso.jpg)
Meredith Amoroso
Philips Global Press Office Tel: +1 724-584-8991
By clicking on the link, you will be leaving the official Royal Philips ("Philips") website. Any links to third-party websites that may appear on this site are provided only for your convenience and in no way represent any affiliation or endorsem*nt of the information provided on those linked websites. Philips makes no representations or warranties of any kind with regard to any third-party websites or the information contained therein.
You are about to visit a Philips global content page
Related news
-
June 14, 2024
New study shows AI performs as well as expert echocardiographers at recognizing abnormal heart wall movement
News article
-
May 17, 2024
Philips highlights clinical evidence at HRS 2024
News article
-
May 14, 2024
‘Close to the heart’; interventional cardiologist Qaisra Yasmin Saeed M.D. shares Philips’ passion for helping patients and taking on challenges
News article
-
December 08, 2023
EUR 6.5 million Innovative Health Initiative grant set to improve coronary artery disease care
News article
-
August 28, 2023
Philips data shows extended ECG Holter monitoring can improve diagnostic results
News article
-
August 25, 2023
Expert cardiologists discuss the role of ultrasound in multimodal imaging for heart failure at ESC 2023
News article
-
June 22, 2023
Philips helps deliver diagnostic confidence in echocardiography with Ultrasound Compact 5500CV at ASE 2023
News article
-
May 22, 2023
Philips presents findings from retrospective study at HRS 2023, showing AI model’s potential to predict ventricular tachycardia
News article
-
April 12, 2023
Mobile ultrasound's vital role in underserved cardiac care
News article
-
March 02, 2023
Philips comprehensive cardiology portfolio showcased at ACC/WCC 2023
News article
-
December 15, 2022
News article
-
September 29, 2022
Enhancing cardiac care to meet the evolving needs of clinicians and patients
News article
- About us
- News center
- Dutch introduction Philips ePatch
- News center
-
Consumer products
- Consumer products
- Home
- Support
- Product registration
- My Philips
-
Healthcare professionals
- Healthcare professionals
- Home
- Products
- Services
- Specialties
- Solutions
-
Other business solutions
- Other business solutions
- Lighting
- Automotive
- Hearing solutions More
- Display solutions
- Dictation Solutions
-
About us
- About us
- Home
- Investor Relations
- Careers More
- Innovation
- Environmental, Social and Governance
- Suppliers
-
- Contact & support
- Customer support
- Professional healthcare support
- Company contacts
-
Stay up-to-date
Stay up-to-date
Subscribe to our news
-
Select country
Global (English)
- Privacy Notice
- Terms of use
- Cookie notice
© Koninklijke Philips N.V., 2004 - 2024. All rights reserved.
By clicking on the link, you will be leaving the official Royal Philips ("Philips") website. Any links to third-party websites that may appear on this site are provided only for your convenience and in no way represent any affiliation or endorsem*nt of the information provided on those linked websites. Philips makes no representations or warranties of any kind with regard to any third-party websites or the information contained therein.
You are about to visit a Philips global content page
Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.